Crossmark

Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson’s disease without dementia: a systematic review

Crossref DOI link: https://doi.org/10.1136/bmjno-2025-001079

Published Online: 2025-08-03

Published Print: 2025-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Cani, Ilaria

Grotteschi, Nicola

Calandra-Buonaura, Giovanna https://orcid.org/0000-0002-9447-3532
Guarino, Maria

Guaraldi, Pietro

Giannini, Giulia

Baldelli, Luca https://orcid.org/0000-0003-3666-1735
Donati, Monia

Cortelli, Pietro https://orcid.org/0000-0002-3633-8818
Camerlingo, Maria Domenica

Nonino, Francesco

Sambati, Luisa https://orcid.org/0000-0002-5939-7933
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04226248 at ClinicalTrials.gov

Documents that mention this clinical trial

Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson’s disease without dementia: a systematic review
https://doi.org/10.1136/bmjno-2025-001079
License Information

License valid from 2025-08-01

Document is current

Any future updates will be listed below